EyePoint (EYPT) Prepaid Assets (2011 - 2026)

EyePoint (EYPT) reported Prepaid Assets of $1.3 million for Q1 2026, down 79.5% on a YoY basis from $6.2 million in Q1 2025, and down 63.73% sequentially from $3.5 million in Q4 2025.

EyePoint (EYPT) Prepaid Assets (2011 - 2026) Analysis & Trends

EyePoint (EYPT) has 16 years of Prepaid Assets data on file, last reported at $1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets fell 79.5% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (down 79.5% YoY), and the FY2025 full-year result was $3.5 million, up 50.28% from the prior year.
  • Prepaid Assets slipped to $1.3 million in Q1 2026, from $3.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $11.1 million in Q1 2024 to a low of $782000.0 in Q4 2022.
  • A 5-year average of $5.4 million and a median of $5.9 million in 2022 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets slumped 81.46% in 2022 and surged 364.83% in 2024, its largest moves.
  • Tracing EYPT's Prepaid Assets over 5 years: stood at $782000.0 in 2022, then jumped by 116.75% to $1.7 million in 2023, then surged by 37.99% to $2.3 million in 2024, then surged by 50.28% to $3.5 million in 2025, then sank by 63.73% to $1.3 million in 2026.
  • Business Quant data shows EYPT's Prepaid Assets at $1.3 million in Q1 2026, $3.5 million in Q4 2025, and $899000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1.28 Mn
Dec 31, 2025 3.52 Mn
Sep 30, 2025 899,000.00
Jun 30, 2025 6.22 Mn
Mar 31, 2025 6.22 Mn
Dec 31, 2024 2.34 Mn
Sep 30, 2024 2.44 Mn
Jun 30, 2024 9.64 Mn
Mar 31, 2024 11.09 Mn
Dec 31, 2023 1.70 Mn
Sep 30, 2023 9.09 Mn
Jun 30, 2023 2.07 Mn
Mar 31, 2023 9.08 Mn
Dec 31, 2022 782,000.00
Sep 30, 2022 10.44 Mn
Jun 30, 2022 8.85 Mn
Mar 31, 2022 5.92 Mn
Dec 31, 2021 4.22 Mn
Sep 30, 2021 3.89 Mn
Jun 30, 2021 3.70 Mn